A Placebo-controlled, Double-blind, Randomized Trial to Compare the Effect of Treatment on Plaque Burden as Determined by Intravascular Ultrasound and to Evaluate the Efficacy, Pharmacokinetics, Safety, and Tolerability of MDCO-216 Given as Multiple Weekly Infusions in Subjects With a Recent Acute Coronary Syndrome

Trial Profile

A Placebo-controlled, Double-blind, Randomized Trial to Compare the Effect of Treatment on Plaque Burden as Determined by Intravascular Ultrasound and to Evaluate the Efficacy, Pharmacokinetics, Safety, and Tolerability of MDCO-216 Given as Multiple Weekly Infusions in Subjects With a Recent Acute Coronary Syndrome

Discontinued
Phase of Trial: Phase I/II

Latest Information Update: 17 Jul 2017

At a glance

  • Drugs MDCO 216 (Primary)
  • Indications Acute coronary syndromes
  • Focus Proof of concept; Therapeutic Use
  • Acronyms MILANO PILOT; PILOT
  • Sponsors The Medicines Company
  • Most Recent Events

    • 12 Jan 2017 This trial was completed in Netherlands, according to European Clinical Trials Database.
    • 15 Dec 2016 This trial has been completed in Czech Republic (end date: 26 Oct 2016), according to European Clinical Trials Database.
    • 10 Dec 2016 This trial has been completed in Poland (end date: 2016-10-26), according to European Clinical Trials Database.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top